MicroRNA
Title:Editorial: (Thematic Issue: MicroRNAs: Non Coding Pleiotropic Factors in Development, Cancer Prevention and Treatment)
Volume: 2 Issue: 2
Author(s): Francesco Fazi and Giovanni Blandino
Affiliation:
Export Options
About this article
Cite this article as:
Fazi Francesco and Blandino Giovanni, Editorial: (Thematic Issue: MicroRNAs: Non Coding Pleiotropic Factors in Development, Cancer Prevention and Treatment), MicroRNA 2013; 2 (2) . https://dx.doi.org/10.2174/2211536611302020001
DOI https://dx.doi.org/10.2174/2211536611302020001 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
Call for Papers in Thematic Issues
Modulatory Roles of Non-coding RNAs in cancer therapy
This thematic issue aims to elucidate the most recent research on ncRNAs in CRCs and discuss the importance and difficulties that may arise in applying this tool on a regular clinical basis.read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Head and Neck Cancer with Lung Metastases: Treatment Challenges
Clinical Cancer Drugs Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer
Mini-Reviews in Medicinal Chemistry CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Development of Drug Targeting and Delivery in Cervical Cancer
Current Cancer Drug Targets Molecular Docking of 4-ethoxychalcones on Oxidoreductase/Pirin Inhibitors and Cytotoxic Evaluation on Breast/Skin Cancer Cell Lines
Letters in Drug Design & Discovery An Evidence-Based Review of the Mechanism of Action, Efficacy, and Safety of Biologic Therapies in the Treatment of Psoriasis and Psoriatic Arthritis
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Editorial [Developmental Genes and Cancer]
Current Drug Targets ATP Synthesis Revisited: New Avenues for the Management of Mitochondrial Diseases
Current Pharmaceutical Design A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)]
Anti-Cancer Agents in Medicinal Chemistry Pharmacophore Modeling, Docking and Molecular Dynamics Studies on Caspase-3 Activators Binding at β-Tubulin Site
Current Computer-Aided Drug Design DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Current Medicinal Chemistry Hematological Targets of Radiation Damage
Current Drug Targets Cross-Talk Between Mesenchymal Stem/Stromal Cells and Dendritic Cells
Current Stem Cell Research & Therapy The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy
Current Molecular Imaging (Discontinued) Recent Patents on Oral Vaccine Design
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery